Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 28;117(7):1326–1337. doi: 10.1160/TH16-10-0793

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.

PMC Copyright notice

Figure 3: Treatment strategy overall (A and C) and within countries with DOAC launch at study commencement (B and D) — . DOAC, direct oral anticoagulant; DVT, deep-vein thrombosis; PE, pulmonary embolism; VKA, vitamin K antagonist. Multiple options possible for any one patient. DOAC launched countries are Germany, Austria, Switzerland, France and UK; Non-DOAC countries are Italy and Spain. *Delay in peak effect after initiation (2–5 days).